Prestige Consumer Healthcare Research and Development Expense (TTM) Analysis

Prestige Consumer Healthcare, Inc. (PBH)

52.84 +0.20 (+0.38%) USD | NYSE | Sep 02, 16:00

52.84 0.00 (0.00%) After-Hours: 17:06

View Research and Development Expense (TTM) for PBH.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Research and Development Expense (TTM) Chart

Start Trial

View and export this data back to . Start Trial.

Date	Value

R&D expense is a line item from many companies' income statements.

View Research and Development Expense (TTM) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Research and Development Expense (TTM) Benchmarks

Start Trial

Indivior Pharmaceuticals, Inc.	53.00M
ANI Pharmaceuticals, Inc.	49.91M
Corcept Therapeutics, Inc.	253.86M
Veru, Inc.	11.76M
Johnson & Johnson	15.06B